Loading
Tumours recruit the body's clean-up cells (macrophages and immature myeloid cells) and re-train them as bodyguards. They switch off T cells, build vessels, and, when a therapeutic antibody flags a cancer cell for eating, are told 'don't eat me' by CD47 on its surface.
Tumour and stromal CSF1, CCL2, CXCL1/2/8, VEGF, G-CSF and IL-6 recruit monocytes and neutrophils and expand myeloid-derived suppressor cells (PMN- and M-MDSC) from the bone marrow. In the tumour, hypoxia, lactate, IL-4/IL-13 and IL-10 polarise macrophages toward an immunosuppressive TAM state (TREM2+, SPP1+, MRC1+) that secretes IL-10, TGF-β, arginase, PGE2, expresses PD-L1, SIRPα and VISTA, and promotes angiogenesis and metastasis (TMEM doorways). MDSCs suppress via arginase, iNOS, ROS and PD-L1. CD47 on tumour cells binds SIRPα to block phagocytosis; magrolimab (anti-CD47) failed in AML/MDS after promising phase 1 data, but CD47 remains pursued with bispecifics. CSF1R inhibition (pexidartinib, vimseltinib in tenosynovial giant cell tumour) depletes TAMs but compensatory MDSC influx blunts it in cancer; CD40 agonists and TLR agonists reprogram; CXCR2 and CCR2 blockade limit recruitment; STAT3 and PI3Kγ inhibitors reprogram. Trained immunity (BCG) and engineered CAR-macrophages try to conscript the same cells for the attack.
A landlord who hires the neighbourhood's own bouncers, pays them in sugar and lactate, and hangs a sign on every door that reads 'don't touch, friend' (CD47). The police (T cells) are stopped at the door by the bouncers, and the cleaners (macrophages) read the sign and leave.
The reference for why pancreatic microenvironment trials read as a list of failures and what the field now means by remodelling rather than removing the stroma.
One pathway page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Shares The tumour microenvironment in pancreatic cancer: clinical challenges and opportunities, Immune exclusion, JAK-STAT signalling, Microenvironment and inflammation: tumours as wounds that do not heal and the tags mechanism, mechanics-atlas.
Shares Myeloid-derived suppressor cells (MDSCs), CXCR4, CSF1R, VEGF / VEGFR and the tags mechanism, mechanics-atlas.
Shares Fc engineering / effector function, Complement in cancer, CAR-NK & CAR-macrophage, Monoclonal antibodies and the tags mechanism, mechanics-atlas.
Shares CSF1R, The angiogenic switch & tumour vessels, VEGF / VEGFR and the tags mechanism, mechanics-atlas.
Shares CD30, Microenvironment and inflammation: tumours as wounds that do not heal, PD-L1, Hodgkin lymphoma and the tags mechanism, mechanics-atlas.
Shares Nutrient competition & metabolic immunosuppression, MYC and the tags mechanism, mechanics-atlas.
Shares Complement in cancer, Immune checkpoint inhibitors and the tags mechanism, mechanics-atlas.
Shares Cold tumours: immune deserts and exclusion, VEGF / VEGFR, PD-L1, Immune checkpoint inhibitors and the tags mechanism, mechanics-atlas.